Missing a GLP‑1 dose doesn't have to derail your progress. Here's exactly when to take a late dose vs. skip it entirely for every major GLP‑1 medication, plus how to prevent missed doses in the future.
Read More →Acid reflux and GERD affect 9 to 15 percent of GLP‑1 users in clinical trials, driven by delayed gastric emptying. Learn why it happens, what makes it worse, and how to manage it effectively.
Read More →Fatigue affects about 11 percent of semaglutide users in clinical trials and is often linked to reduced calorie intake, dehydration, or protein deficiency. Learn why it happens and how to manage it.
Read More →Several next-generation obesity medications are approaching FDA decisions, including retatrutide with 28.7 percent weight loss in Phase 3 and CagriSema with 22.7 percent. Here is what the pipeline looks like heading into 2027.
Read More →
